Ely Health Station

Ely Health Station's outpatient program emphasizes medication-assisted treatment as the cornerstone of recovery support. The center provides both buprenorphine and naltrexone options, allowing clinicians to match medication protocols with individual recovery needs and substance use patterns.

Buprenorphine treatment helps stabilize individuals recovering from opioid use disorder, reducing cravings and withdrawal symptoms while supporting long-term recovery goals. Naltrexone protocols serve both alcohol and opioid use disorders, blocking euphoric effects and supporting sobriety maintenance. These medications integrate with ongoing counseling and support services throughout the recovery process.

Located in Ely's White Pine County, the recovery center addresses significant treatment gaps across eastern Nevada's rural landscape. The facility serves communities where addiction treatment options remain limited, providing consistent outpatient services Monday through Friday with extended 8 AM to 7 PM hours.

Transportation challenges and geographic isolation often complicate recovery efforts in rural areas. Ely Health Station's extended weekday schedule accommodates work commitments and travel distances, while their tribal government healthcare status brings additional cultural competency to treatment approaches. The center's focus on outpatient care allows individuals to maintain family and employment connections while accessing professional addiction treatment.

The recovery center accepts both Medicaid and Medicare, plus offers sliding scale fee structures to expand treatment access across income levels. Private pay options provide additional flexibility for individuals seeking outpatient addiction treatment services.

These multiple payment approaches recognize the economic realities facing rural Nevada communities, where insurance coverage and income levels vary significantly. The sliding scale fee structure particularly supports individuals who may not qualify for government insurance but face financial barriers to private treatment costs.